Evidence map›Paper›PMID 42655869›Full record

ArticlePhysiological reports2026

Plasma proenkephalin-a facilitates measurement of human kidney functional reserve: From healthy kidney donors to polymorbid patients.

Camila Eleuterio Rodrigues, Amy Y M Au, Daniel Rebello, Maria Maawad, Florian Uhle, Jonathan Erlich, Zoltan H Endre

Abstract read
In one paragraph

Article in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Camila Eleuterio RodriguesSchool of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0003-0562-0893
Amy Y M AuSchool of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Daniel RebelloSchool of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Maria MaawadDepartment of Nephrology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
Florian UhleSphingoTec GmbH, Hennigsdorf, Germany.
Jonathan ErlichSchool of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Zoltan H EndreSchool of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-4782-8695

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2019/19631-7Lewis FoundationPrince of Wales Hospital Foundation (POWHF)Sphingotec GmbH (SphingoTec)
6 · The paper itself

Abstract

Reduced kidney functional reserve, KFR, predicts poor outcomes in kidney diseases. We compared plasma proenkephalin-A, plasma cystatin C, and creatinine clearance for kidney functional reserve measurement. KFR was measured preoperatively in 40 patients undergoing cardiac surgery and 22 healthy participants, including 14 kidney donors. Plasma proenkephalin-A, cystatin C, and creatinine levels were compared before and after a protein meal for KFR calculation. Baseline creatinine clearance correlated poorly with baseline estimated glomerular filtration rate measured by any method. Cystatin C and proenkephalin-A nadir after protein occurred earlier. The proenkephalin-A-based KFR had a greater dynamic range than cystatin C- and creatinine clearance-based KFR (median [IQR] fractional KFR: proenkephalin-A 44.2% [35.5; 58.0]; cystatin C 10.5% [4.4; 16.2]; creatinine clearance 30.0% [8.4; 68.9], p < 0.0001). Measurements were more homogeneous with cystatin C- and proenkephalin-A-estimated glomerular filtration rate than creatinine clearance (higher intraclass correlation: 0.98 for cystatin C; 0.86 for proenkephalin-A, and 0.63 for creatinine clearance). The median [IQR] absolute proenkephalin-A- and cystatin C-based KFR were higher in healthy participants (proenkephalin-A-KFR: 33.8 [26.6; 59.0], cystatin C-KFR: 11.6 [6.6; 15.1] mL/min/1.73m

Indexed as

EnkephalinsKidneyProtein PrecursorsAgedBiomarkersCreatinineCystatin CFemaleGlomerular Filtration RateHumansKidney Function TestsMaleMiddle AgedBiomarkersCreatinineCystatin CEnkephalinsproenkephalinProtein Precursorscreatinine secretioncystatin Ckidney functional reserveproenkephalin‐Asubclinical chronic kidney disease

Identifiers

PMID42655869
PMCPMC13519117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.